Literature DB >> 29050494

Whole transcriptome analysis identifies differentially regulated networks between osteosarcoma and normal bone samples.

Xuan Dung Ho1,2, Phuong Phung1, Van Q Le3, Van H Nguyen3, Ene Reimann2,4, Ele Prans2, Gea Kõks2, Katre Maasalu5,6, Nghi Tn Le7, Le H Trinh3, Hoang G Nguyen3, Aare Märtson5,6, Sulev Kõks2,4.   

Abstract

We performed whole transcriptome analysis of osteosarcoma bone samples. Initially, we sequenced total RNA from 36 fresh-frozen samples (18 tumoral bone samples and 18 non-tumoral paired samples) matching in pairs for each osteosarcoma patient. We also performed independent gene expression analysis of formalin-fixed paraffin-embedded samples to verify the RNAseq results. Formalin-fixed paraffin-embedded samples allowed us to analyze the effect of chemotherapy. Data were analyzed with DESeq2, edgeR and Reactome packages of R. We found 5365 genes expressed differentially between the normal bone and osteosarcoma tissues with an FDR below 0.05, of which 3399 genes were upregulated and 1966 were downregulated. Among those genes, BTNL9, MMP14, ABCA10, ACACB, COL11A1, and PKM2 were expressed differentially with the highest significance between tumor and normal bone. Functional annotation with the reactome identified significant changes in the pathways related to the extracellular matrix degradation and collagen biosynthesis. It was suggested that chemotherapy may induce the modification of ECM with important collagen biosynthesis. Taken together, our results indicate that changes in the degradation of extracellular matrix seem to be an important mechanism of osteosarcoma and efficient chemotherapy induces the genes related to bone formation. Impact statement Osteosarcoma is a rare disease but it is of interest to many scientists all over the world because the current standard treatment still has poor results. We sequenced total RNA from 36 fresh-frozen paired samples (18 tumoral bone samples and 18 non-tumoral paired samples) from osteosarcoma patients. We found that differences in the gene expressions between the normal and affected bones reflected the changes in the regulation of the degradation of collagen and extracellular matrix. We believe that these findings contribute to the understanding of OS and suggest ideas for further studies.

Entities:  

Keywords:  Osteosarcoma; RNA sequencing; gene expression profiling; high-through put nucleotide sequencing; osteogenic sarcoma; transcriptome

Mesh:

Year:  2017        PMID: 29050494      PMCID: PMC5714151          DOI: 10.1177/1535370217736512

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  39 in total

1.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

2.  Serum miR-195 is a diagnostic and prognostic marker for osteosarcoma.

Authors:  Haikang Cai; Hui Zhao; Jie Tang; Haishan Wu
Journal:  J Surg Res       Date:  2014-11-21       Impact factor: 2.192

Review 3.  Translational biology of osteosarcoma.

Authors:  Maya Kansara; Michele W Teng; Mark J Smyth; David M Thomas
Journal:  Nat Rev Cancer       Date:  2014-10-16       Impact factor: 60.716

4.  Screening of diagnostic markers for osteosarcoma.

Authors:  Dajiang Wu; Kai Chen; Yushu Bai; Xiaodong Zhu; Ziqiang Chen; Chuanfeng Wang; Yingchuan Zhao; Ming Li
Journal:  Mol Med Rep       Date:  2014-09-08       Impact factor: 2.952

5.  Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program.

Authors:  Lisa Mirabello; Rebecca J Troisi; Sharon A Savage
Journal:  Cancer       Date:  2009-04-01       Impact factor: 6.860

6.  Differential expression analysis for sequence count data.

Authors:  Simon Anders; Wolfgang Huber
Journal:  Genome Biol       Date:  2010-10-27       Impact factor: 13.583

7.  The influence of MMP-14, TIMP-2 and MMP-2 expression on breast cancer prognosis.

Authors:  Bernard Têtu; Jacques Brisson; Chang Shu Wang; Hélène Lapointe; Geneviève Beaudry; Caty Blanchette; Dominique Trudel
Journal:  Breast Cancer Res       Date:  2006-06-15       Impact factor: 6.466

8.  Sequence biases in large scale gene expression profiling data.

Authors:  Asim S Siddiqui; Allen D Delaney; Angelique Schnerch; Obi L Griffith; Steven J M Jones; Marco A Marra
Journal:  Nucleic Acids Res       Date:  2006-07-13       Impact factor: 16.971

9.  edgeR: a Bioconductor package for differential expression analysis of digital gene expression data.

Authors:  Mark D Robinson; Davis J McCarthy; Gordon K Smyth
Journal:  Bioinformatics       Date:  2009-11-11       Impact factor: 6.937

10.  Global gene expression profiling of human pleural mesotheliomas: identification of matrix metalloproteinase 14 (MMP-14) as potential tumour target.

Authors:  Stefania Crispi; Raffaele A Calogero; Mario Santini; Pasquale Mellone; Bruno Vincenzi; Gennaro Citro; Giovanni Vicidomini; Silvia Fasano; Rosaria Meccariello; Gilda Cobellis; Simona Menegozzo; Riccardo Pierantoni; Francesco Facciolo; Alfonso Baldi; Massimo Menegozzo
Journal:  PLoS One       Date:  2009-09-15       Impact factor: 3.240

View more
  21 in total

1.  The Role of Omega-3 Polyunsaturated Fatty Acids from Different Sources in Bone Development.

Authors:  Reut Rozner; Janna Vernikov; Shelley Griess-Fishheimer; Tamar Travinsky; Svetlana Penn; Betty Schwartz; Ronit Mesilati-Stahy; Nurit Argov-Argaman; Ron Shahar; Efrat Monsonego-Ornan
Journal:  Nutrients       Date:  2020-11-13       Impact factor: 5.717

2.  Alternative splicing of leptin receptor overlapping transcript in osteosarcoma.

Authors:  Emel Rothzerg; Xuan D Ho; Jiake Xu; David Wood; Aare Märtson; Katre Maasalu; Sulev Kõks
Journal:  Exp Biol Med (Maywood)       Date:  2020-08-12

Review 3.  At the dawn of the transcriptomic medicine.

Authors:  Gea Koks; Abigail L Pfaff; Vivien J Bubb; John P Quinn; Sulev Koks
Journal:  Exp Biol Med (Maywood)       Date:  2020-09-11

4.  Targeting the Wnt/β-catenin pathway in human osteosarcoma cells.

Authors:  Fang Fang; Ashley VanCleave; Ralph Helmuth; Haydee Torres; Kirby Rickel; Hannah Wollenzien; Hongli Sun; Erliang Zeng; Jing Zhao; Jianning Tao
Journal:  Oncotarget       Date:  2018-12-04

Review 5.  MMP14 in Sarcoma: A Regulator of Tumor Microenvironment Communication in Connective Tissues.

Authors:  Jordi Gonzalez-Molina; Silvia Gramolelli; Zehuan Liao; Joseph W Carlson; Päivi M Ojala; Kaisa Lehti
Journal:  Cells       Date:  2019-08-28       Impact factor: 6.600

Review 6.  Pannexin 3 channels in health and disease.

Authors:  Brooke L O'Donnell; Silvia Penuela
Journal:  Purinergic Signal       Date:  2021-07-12       Impact factor: 3.765

7.  The predictive prognostic values of CBFA2T3, STX3, DENR, EGLN1, FUT4, and PCDH7 in lung cancer.

Authors:  Yuhao Chen; Lu Shen; Bairong Chen; Xiao Han; Yunchi Yu; Xiaosa Yuan; Lou Zhong
Journal:  Ann Transl Med       Date:  2021-05

8.  ICG-001, an Inhibitor of the β-Catenin and cAMP Response Element-Binding Protein Dependent Gene Transcription, Decreases Proliferation but Enhances Migration of Osteosarcoma Cells.

Authors:  Geoffroy Danieau; Sarah Morice; Sarah Renault; Régis Brion; Kevin Biteau; Jérôme Amiaud; Marie Cadé; Dominique Heymann; Frédéric Lézot; Franck Verrecchia; Françoise Rédini; Bénédicte Brounais-Le Royer
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-01

9.  Single-cell RNA sequencing of human femoral head in vivo.

Authors:  Xiang Qiu; Ying Liu; Hui Shen; Zun Wang; Yun Gong; Junxiao Yang; Xiaohua Li; Huixi Zhang; Yu Chen; Cui Zhou; Wanqiang Lv; Liang Cheng; Yihe Hu; Boyang Li; Wendi Shen; Xuezhen Zhu; Li-Jun Tan; Hong-Mei Xiao; Hong-Wen Deng
Journal:  Aging (Albany NY)       Date:  2021-06-10       Impact factor: 5.682

10.  Bioinformatics identification of crucial genes and pathways associated with hepatocellular carcinoma.

Authors:  Xueren Gao; Xixi Wang; Shulong Zhang
Journal:  Biosci Rep       Date:  2018-11-09       Impact factor: 3.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.